Evaluating the User Preference and Level of Insulin Self-Administration Adherence in Young Patients With Type 1 Diabetes: Experience With Two Insulin Pen Needle Lengths

Curēus
Ayman Al Hayek, Mohamed Al Dawish

Abstract

Background Selecting the appropriate insulin pen needle is important to reduce pain and injection-related adverse events like insulin leakage. It also helps to improve medication adherence and glycemic control in patients with type 1 diabetes mellitus (T1DM). Objective This study aimed to compare the 6-mm and 8-mm 32.5-gauge insulin pen needles in terms of glycemic control, pain score, user preference, medication adherence, and injection adverse events in patients with T1DM. Methods We conducted a prospective cohort study of 62 patients with T1DM. All patients constituted an experimental group initially and then changed the length of the needle to be part of a self-control group. The glycemic control, visual analog scale (VAS) pain score, Morisky Medication Adherence Scale (MMAS) score, needle attribute score, and injection-related adverse events were measured for all patients with both lengths of needles. Patients were assessed at the baseline visit and followed up for three months. Statistical comparisons were done by the chi-squared test, paired t-test, and paired Wilcoxon test when appropriate with a two-tailed alpha level below 0.05 indicating statistical significance. Results With the NanoPass® 32.5-gauge, 6-mm needle (Te...Continue Reading

References

Nov 1, 1988·Psychological Medicine·H M McCormackS Sheather
Sep 13, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·E D MollemaH M van der Ploeg
Nov 11, 2005·American Journal of Therapeutics·Ji-Won Yoon, Hee-Sook Jun
May 6, 2008·The Journal of Clinical Hypertension·Donald E MoriskyHarry J Ward
Mar 14, 2009·Journal of Diabetes and Its Complications·Maysaa KhattabKamel Ajlouni
May 9, 2009·Current Medical Research and Opinion·Alex Z FuLarry Radican
Sep 17, 2009·Pediatric Diabetes·Marian RewersGeorgeanna J Klingensmith
Oct 12, 2010·Diabetes & Metabolism·A FridUNKNOWN Scientific Advisory Board for the Third Injection Technique Workshop
Aug 26, 2011·Expert Opinion on Drug Delivery·Birtha Hansen, Irina Matytsina
Apr 30, 2013·Diabetes Technology & Therapeutics·Yoshio NagaiYasushi Tanaka
May 2, 2015·Indian Journal of Endocrinology and Metabolism·Nikhil TandonSubhash K Wangnoo
Jan 12, 2017·BMJ Open Diabetes Research & Care·Kezia A PræstmarkBente M Stallknecht
Oct 14, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Inna V MisnikovaAlexander V Dreval

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.